Original articleClinical endoscopyColonoscopy utilization and outcomes 2000 to 2011
Section snippets
CORI
We developed a consortium of diverse clinical practice settings. Endoscopists use a structured computerized endoscopic report generator to produce endoscopic reports. The data that are transmitted from the local site to the National Endoscopic Database does not contain most patient or provider identifiers and qualifies as a Limited Data Set under the Code of Federal Regulations (45 CFR §164.514[e][2]). This analysis of the National Endoscopic Database is approved by the Oregon Health and
Results
From 2000 to 2011, we received 1,372,838 colonoscopy reports regarding 1,169,457 patients from 84 endoscopy practice sites. A total of 1,218,085 reports came from centers other than VA medical centers.
Discussion
This is the largest analysis of colonoscopy practice that has ever been reported from data sources not related to claims in the United States. The direct entry of data by the endoscopist provides data unavailable in claims data, such as detailed procedure findings (polyp descriptors) and quality.
Acknowledgment
We thank Dr Doug Levine for his advice about data analysis.
References (20)
- et al.
Burden of digestive diseases in the United States Part II: lower gastrointestinal diseases
Gastroenterology
(2009) - et al.
Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?
Gastroenterology
(2004) - et al.
Prevalence of polyps greater than 9 mm in a consortium of diverse clinical practice settings in the United States
Clin Gastroenterol Hepatol
(2005) - et al.
Utilization of colonoscopy in the United States: results from a national consortium
Gastrointest Endosc
(2005) - et al.
Polyp size and advanced histology in patients undergoing colonoscopy screening: implications for CT colonography
Gastroenterology
(2008) - et al.
Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database
Gastrointest Endosc
(2008) - et al.
Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis
Clin Gastroenterol Hep
(2009) - et al.
Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy
Gastroenterology
(2010) - et al.
The difference in colon polyp size before and after removal
Gastrointest Endosc
(1996) - et al.
The pathologic measurement of polyp size is preferable to endoscopic estimate
Gastrointest Endosc
(1997)
Cited by (103)
The Diagnostic Performance of Fecal Immunochemical Tests for Detecting Advanced Neoplasia at Surveillance Colonoscopy
2024, Clinical Gastroenterology and HepatologyOrganic colonic lesions in patients with irritable bowel syndrome: A comparative study
2023, Revista de Gastroenterologia de MexicoPolyp characteristics at screening colonoscopy and post-colonoscopy colorectal cancer mortality: a retrospective cohort study
2023, Gastrointestinal EndoscopyRight-Sizing Colonoscopy Surveillance Recommendations
2023, Gastro Hep Advances
DISCLOSURE: This project was supported with funding from National Institute of Diabetes and Digestive and Kidney Diseases U01DK57132, R33-DK61778-01, and R21-CA131626 and Ironwood Pharmaceuticals. D. Lieberman is director of the Clinical Outcomes Research Initiative. In addition, the practice network (Clinical Outcomes Research Initiative) has received support from the following entities to support the infrastructure of the practice-based network: AstraZeneca, Novartis, Bard International, Pentax USA, ProVation, Endosoft, Given Imaging, and Ethicon. The latter commercial entities had no involvement in this research. No other financial relationships relevant to this publication were disclosed.